A Study of Bleximenib in Combination With Acute Myeloid Leukemia (AML) Directed Therapies

PHASE1RecruitingINTERVENTIONAL
Enrollment

200

Participants

Timeline

Start Date

October 4, 2022

Primary Completion Date

October 8, 2024

Study Completion Date

March 19, 2027

Conditions
Leukemia, Myeloid, Acute
Interventions
DRUG

Bleximenib

Participants will receive bleximenib.

DRUG

Venetoclax (VEN)

Participants will receive VEN.

DRUG

Azacitidine (AZA)

Participants will receive AZA.

DRUG

Cytarabine

Participants will receive cytarabine.

DRUG

Daunorubicin or Idarubicin

Participants will receive daunorubicin or idarubicin.

Trial Locations (32)

2145

RECRUITING

Westmead Hospital, Westmead

3000

RECRUITING

Peter MacCallum Cancer Centre, Melbourne

3168

RECRUITING

Monash Medical Centre, Clayton

8035

RECRUITING

Hosp Univ Vall D Hebron, Barcelona

10461

RECRUITING

Albert Einstein College Of Medicine, New York

13273

ACTIVE_NOT_RECRUITING

Institut Paoli Calmettes, Marseille

13353

ACTIVE_NOT_RECRUITING

Charite Universitaetsmedizin Berlin, Berlin

20089

RECRUITING

IRCCS Istituto Clinico Humanitas, Rozzano

20162

RECRUITING

ASST Grande Ospedale Metropolitano Niguarda, Milan

27103

RECRUITING

Novant Health Forsyth Medical Center, Winston-Salem

28040

RECRUITING

Hosp Univ Fund Jimenez Diaz, Madrid

28204

RECRUITING

Novant Health, Charlotte

31008

RECRUITING

Clinica Univ. de Navarra, Pamplona

31100

RECRUITING

Institut Universitaire du Cancer Toulouse Oncopole, Toulouse

35033

RECRUITING

Chu Rennes Hopital Pontchaillou, Rennes

35233

COMPLETED

The University of Alabama at Birmingham, Birmingham

37044

RECRUITING

CHU de Tours - Hôpital de Bretonneau, Tours

40138

RECRUITING

Azienda Opedaliero-Universitaria Policlinico Sant'orsola Malpighi di Bologna, Bologna

47014

RECRUITING

Istituto Scientifico Romagnolo per lo Studio e la Cura dei Tumori, Meldola

69120

ACTIVE_NOT_RECRUITING

Universitaetsklinikum Heidelberg, Heidelberg

77030

RECRUITING

MD Anderson, Houston

89081

ACTIVE_NOT_RECRUITING

Universitatsklinikum Ulm, Ulm

91010

RECRUITING

City of Hope, Duarte

02114

RECRUITING

Massachusetts General Hospital, Boston

M5G 1Z5

ACTIVE_NOT_RECRUITING

Princess Margaret Cancer Centre University Health Network, Toronto

01307

ACTIVE_NOT_RECRUITING

Universitatsklinikum Carl Gustav Carus Dresden, Dresden

04103

COMPLETED

Universitaetsklinikum Leipzig, Leipzig

08025

RECRUITING

Hosp. de La Santa Creu I Sant Pau, Barcelona

08036

RECRUITING

Hosp Clinic de Barcelona, Barcelona

NW1 2PG

RECRUITING

University College London Hospitals NHSFT, London

M20 4BX

RECRUITING

Christie Hospital NHS Trust, Manchester

OX3 7LE

ACTIVE_NOT_RECRUITING

Oxford University Hospitals NHS Trust, Oxfordshire

All Listed Sponsors
lead

Janssen Research & Development, LLC

INDUSTRY